Dr. Slavcev’s research specializes in bacteriophage-based biotechnology and exploits phage genetic systems and phage themselves in the generation of novel therapeutic platforms. With particular focus on coliphages, his lab’s research designs and constructs vectors for novel vaccines, gene delivery systems and immunotherapeutics. In addition his team identifies and applies novel phage genomic anti-bacterial genes with potential phage therapy applications. Research in the Slavcev lab is heavily multidisciplinary, integrating genetics, molecular biology, microbiology, gene therapy, virology, therapeutic design, and synthetic in vivo biology.